Recent developments in the prevention of chemotherapy-induced nausea and vomiting (CINV): a comprehensive review.

@article{Jordan2015RecentDI,
  title={Recent developments in the prevention of chemotherapy-induced nausea and vomiting (CINV): a comprehensive review.},
  author={Karin Jordan and Franziska Jahn and Matti S. Aapro},
  journal={Annals of oncology : official journal of the European Society for Medical Oncology},
  year={2015},
  volume={26 6},
  pages={1081-90}
}
The prevention of chemotherapy-induced nausea and vomiting (CINV) has been revolutionized over the past 25 years. Guideline-based treatment means that vomiting can be prevented in the majority, but not in all patients. Therefore, antiemetic research continues with the goal of optimizing CINV control for all patients. This comprehensive review summarizes the research efforts in this field over the past few years. Emerging from this research are two new antiemetic agents, netupitant/palonosetron… CONTINUE READING

Connections & Topics

Mentioned Connections BETA
Emerging from this research are two new antiemetic agents , netupitant / palonosetron , the first antiemetic combination agent and rolapitant , a new NK1RA .
Emerging from this research are two new antiemetic agents , netupitant / palonosetron , the first antiemetic combination agent and rolapitant , a new NK1RA .
Emerging from this research are two new antiemetic agents , netupitant / palonosetron , the first antiemetic combination agent and rolapitant , a new NK1RA .
Emerging from this research are two new antiemetic agents , netupitant / palonosetron , the first antiemetic combination agent and rolapitant , a new NK1RA .
Emerging from this research are two new antiemetic agents , netupitant / palonosetron , the first antiemetic combination agent and rolapitant , a new NK1RA .
Emerging from this research are two new antiemetic agents , netupitant / palonosetron , the first antiemetic combination agent and rolapitant , a new NK1RA .
Emerging from this research are two new antiemetic agents , netupitant / palonosetron , the first antiemetic combination agent and rolapitant , a new NK1RA .
Emerging from this research are two new antiemetic agents , netupitant / palonosetron , the first antiemetic combination agent and rolapitant , a new NK1RA .
Emerging from this research are two new antiemetic agents , netupitant / palonosetron , the first antiemetic combination agent and rolapitant , a new NK1RA .
All Topics